Page last updated: 2024-08-23

bucindolol and Tachycardia, Ventricular

bucindolol has been researched along with Tachycardia, Ventricular in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Aleong, RG; Bristow, MR; Liggett, SB; Robertson, AD; Sauer, WH	1

Trials

1 trial(s) available for bucindolol and Tachycardia, Ventricular

Article	Year
Adrenergic receptor polymorphisms and prevention of ventricular arrhythmias with bucindolol in patients with chronic heart failure. Circulation. Arrhythmia and electrophysiology, 2013, Volume: 6, Issue:1 Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Chi-Square Distribution; Female; Heart Failure; Heterozygote; Homozygote; Humans; Male; Middle Aged; Polymorphism, Genetic; Propanolamines; Prospective Studies; Receptors, Adrenergic, alpha-2; Receptors, Adrenergic, beta-1; Stroke Volume; Tachycardia, Ventricular; Treatment Outcome; Ventricular Fibrillation; Ventricular Function, Left	2013

Article

Year

Adrenergic receptor polymorphisms and prevention of ventricular arrhythmias with bucindolol in patients with chronic heart failure.

Circulation. Arrhythmia and electrophysiology, 2013, Volume: 6, Issue:1

Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Chi-Square Distribution; Female; Heart Failure; Heterozygote; Homozygote; Humans; Male; Middle Aged; Polymorphism, Genetic; Propanolamines; Prospective Studies; Receptors, Adrenergic, alpha-2; Receptors, Adrenergic, beta-1; Stroke Volume; Tachycardia, Ventricular; Treatment Outcome; Ventricular Fibrillation; Ventricular Function, Left

2013